approval
saveRECLAST (ZOLEDRONIC ACID) — FDA approval
community read0 votes
Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalZOLEDRONIC ACID — FDA approvalFeb 5, 2026 · 241d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalApr 29, 2020 · 2349d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalJul 7, 2017 · 3376d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalMay 24, 2016 · 3785d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalApr 14, 2016 · 3825d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalApr 16, 2015 · 4189d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalJan 30, 2015 · 4265d ago
- approvalRECLAST (ZOLEDRONIC ACID) — FDA approvalJun 17, 2014 · 4492d ago
same company · ±60 days · 6
- approvalnatalizumab biosimilar: TYRUKO (NATALIZUMAB-SZTN) — FDA approvalFeb 2, 2026
- approvalUNASYN: AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalJan 30, 2026
- approvalUNASYN: AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalJan 27, 2026
- approvalaflibercept biosimilar: ENZEEVU (AFLIBERCEPT-ABZV) — FDA approvalFeb 12, 2026
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026
- approvalGLATIRAMER ACETATE: GLATOPA (GLATIRAMER ACETATE) — FDA approvalFeb 12, 2026
comments(0)
5-min edit window · permanent after that